Horizon Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Horizon Pharma Inc
TickerHZNP
CIK #0001492426
CUSIPG4617B105
SectorLife Sciences - Pharmaceutical Preparations
Address1033 Skokie Blvd Suite 355, Northbrook, IL 60062
Source [EDGAR]
CIK Filing 2011 - 2024
[0001492426] 10-K
[0001492426] 10-Q
[0001492426] 3
[0001492426] 4
[0001492426] 5
[0001492426] 8-K
[0001492426] D
[0001492426] SC 13D
[0001492426] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Horizon Therapeutics Public Ltd Co [2021-02-08] 0.0
Renaissance Technologies LLC Horizon Therapeutics Public Ltd Co [2020-02-12] 5.39
William Blair Investment Management LLC Horizon Pharma PLC [2018-02-13] 5.36
Kingdon Capital Management LLC Horizon Pharma PLC [2017-02-15] 7.83
BlackRock Inc Horizon Pharma PLC [2017-01-30] 8.1
Vanguard Group Inc Horizon Pharma PLC [2016-02-11] 6.0
Lone Pine Capital LLC Horizon Pharma PLC [2015-07-27] 5.4
FMR LLC Horizon Pharma PLC [2015-05-11] 0.0
Kingdon Capital Management LLC Horizon Pharma PLC [2015-02-17] 5.36
Venkataraman Balaji Horizon Pharma PLC [2014-09-23] 15.6
Vidara Therapeutics Holdings LLC Horizon Pharma PLC [2014-09-22] 29.5
Visium Asset Management LP Horizon Pharma Inc [2014-08-07] 5.3
Sutter Hill Ventures Horizon Pharma Inc [2014-05-01] 5.0
Vidara Therapeutics International Ltd Horizon Pharma Inc [2014-03-28] 17.6
Flynn James E Horizon Pharma Inc [2013-12-20] 6.69
Broadfin Capital LLC Horizon Pharma Inc [2013-11-27] 5.89
Atlas Venture Fund VI LP Horizon Pharma Inc [2013-02-11] 6.33
[2012-10-05] None
Tang Capital Partners LP Horizon Pharma Inc [2012-09-21] 9.9
Farallon Capital Management LLC Horizon Pharma Inc [2012-09-17] 5.4
Discovery Group I LLC Horizon Pharma Inc [2012-08-13] 6.5
Sutter Hill Ventures Horizon Pharma Inc [2012-08-02] 5.1
Quaker BioVentures II LP Horizon Pharma Inc [2012-03-09] 11.5
FMR LLC Horizon Pharma Inc [2012-02-14] 0.0
Sutter Hill Ventures Horizon Pharma Inc [2012-02-13] 5.1
Columbia Wanger Asset Management LLC Horizon Pharma Inc [2012-02-10] 7.6
Atlas Venture Fund VI LP Horizon Pharma Inc [2012-02-10] 14.64
Firstmark Capital LLC Horizon Pharma Inc [2012-01-18] 5.4
Form 3/4/5 Filer 2011 - 2024
Horizon Therapeutics Public Ltd Co
Himawan Jeff
Santini Gino
Witz Pascale
Watkins Thomas
Shannon James Samuel
Mahony Susan
Daniel William F
Grey Michael G
Thompson Elizabeth H.Z.
Clayton Sean M.
DesJardin Michael A.
Sherman Jeffrey W
Pasternak Andy
Cox Aaron
McIlvenny Patrick
Walbert Timothy P
Leonardi Jacopo
Hoelscher Paul W.
MOZE Barry
McHugh Miles W
Beeler Brian K
Kent Jeff
Camardo Daniel A.
Curtis Geoffrey M
Karnani Vikram
Konstantinovsky Irina
Rosen Karin
Lin Shao-Lee
Pauli Ronald
Carey Robert
Hampton George P
Mosbrooker Eric
Happel David
Nohria Virinder
Ackerman Timothy J
Thomas John B
Kelly David George
Kody John J
Venkataraman Balaji
de Vaere Robert J
Vidara Therapeutics Holdings LLC
Smith Todd N
Bird Jeffrey W
Adatto Michael
Quaker BioVentures II LP
Formela Jean Francois
Atlas Venture Entrepreneurs Fund VI LP
Atlas Venture Fund VI GmbH & Co KG
Atlas Venture Fund VI LP
Atlas Venture Associates VI, L.P.
Essex Woodlands Health Ventures Fund VII LP
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2023-03-31] SOLE 0.0 21,052,717.0
BlackRock Inc. [2023-03-31] SOLE 13,469,505.0 14,933,931.0
Pentwater Capital Management LP [2023-03-31] SOLE 7,500,000.0 7,500,000.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 7,000,000.0 7,000,000.0
JPMorgan Chase & Co [2023-03-31] DFND 5,391,769.0 5,485,702.0
Farallon Capital Management LLC [2023-03-31] OTR 5,419,823.0 5,419,823.0
State Street Corp [2023-03-31] DFND 4,258,467.0 5,121,833.0
Millennium Management LLC [2023-03-31] SOLE 4,307,754.0 4,838,654.0
Soros Fund Management LLC [2023-03-31] SOLE 4,564,801.0 4,564,801.0
Citadel Advisors LLC [2023-03-31] DFND 4,018,209.0 4,018,209.0
Renaissance Technologies LLC [2023-03-31] SOLE 3,365,491.0 3,368,449.0
Geode Capital Management LLC [2023-03-31] DFND 3,179,053.0 3,179,053.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 1,229,500.0 3,029,711.0
FIL Ltd [2023-03-31] DFND 2,930,911.0 2,967,084.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 2,558,912.0 2,558,912.0
Bank of America Corp /DE/ [2023-03-31] DFND 251,216.0 2,383,595.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 2,222,689.0 2,225,338.0
Psquared Asset Management AG [2023-03-31] SOLE 2,190,845.0 2,190,845.0
Franklin Resources Inc [2023-03-31] DFND 2,174,886.0 2,178,932.0
Morgan Stanley [2023-03-31] DFND 1,721,863.0 2,120,014.0
TIG Advisors LLC [2023-03-31] SOLE 2,105,831.0 2,105,831.0
Balyasny Asset Management LP [2023-03-31] SOLE 2,089,006.0 2,089,006.0
Bank of New York Mellon Corp [2023-03-31] DFND 1,654,837.0 2,039,762.0
Deutsche Bank AG [2023-03-31] DFND 1,729,537.0 1,987,053.0
Westchester Capital Management LLC [2023-03-31] OTR 0.0 1,893,919.0
Hudson Bay Capital Management LP [2023-03-31] OTR 1,833,555.0 1,833,555.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 1,738,146.0
Nuveen Asset Management LLC [2023-03-31] DFND 1,736,958.0 1,736,958.0
Capital International Investors [2023-03-31] DFND 1,600,078.0 1,602,229.0
Barclays PLC [2023-03-31] SOLE 1,582,444.0 1,582,444.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com